Add BrightSurf on Google Email

The American Pediatric Society selects Dr. Joseph L. Wright as the recipient of the 2027 David G. Nichols Health Equity Award

Dr. Joseph L. Wright has been selected as the 2027 David G. Nichols Health Equity Award recipient for his significant contributions to advancing child and adolescent health, well-being, and equity. The award recognizes his decades-long commitment to improving health equity and his transformative contributions to pediatric health.

New aging framework proposes epigenetic regulation as a major limit on human lifespan

A new review proposes the Polycentric Aging Framework, which suggests that epigenetic regulation is a dominant factor limiting human lifespan. The framework identifies three major constraint layers, including epigenetic regulation, irreversible genetic and physical damage, and the accumulation of damaged proteins and organelles.

SourceImpact Journals LLC·JournalAging-US·TypeSystematic review·DateNov 3, 2026

HPV-driven cell death pathways offer new directions for cervical cancer treatment

Research highlights the interconnected regulatory network of programmed cell death pathways in cervical cancer, influenced by HPV-related signaling and the tumor microenvironment. This review proposes targeting multiple pathways, including ferroptosis, to restore cancer-cell susceptibility to destruction and improve treatment responses.

SourceImpact Journals LLC·JournalOncoscience·TypeLiterature review·DateOct 29, 2026

International tumor board explores personalized treatment strategies for colon cancer without measurable disease

The case report highlights the challenges of monitoring residual disease in stage IIIc colon cancer, where conventional imaging shows no measurable tumor but circulating tumor DNA and DNA methylation patterns suggest molecular residual disease. Molecular profiling and international collaboration may help guide treatment decisions in su...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateOct 26, 2026

Rare ovarian cancer diagnosed during early pregnancy highlights diagnostic challenges

A rare case of high-grade serous ovarian carcinoma diagnosed during early gestation at 10 weeks of pregnancy was reported, highlighting the challenges of identifying ovarian malignancy during early pregnancy. The patient underwent surgical management and received adjuvant chemotherapy, and remained disease-free at one-year follow-up.

SourceImpact Journals LLC·JournalOncoscience·TypeCase study·DateOct 8, 2026

Digital Science appoints Charlesworth as strategic sales partner of Altmetric and Dimensions in China’s scholarly publishing sector

Digital Science has appointed Charlesworth as its strategic sales partner for Altmetric and Dimensions in China's scholarly publishing sector. The partnership aims to support the growing demand for research data and information, enabling publishers to access high-quality research insights and understand the reach and attention generate...

Wiley launches two new research journals—Advanced Medicine and Advanced Healthy Aging—Continuing expansion of its Advanced Portfolio

Wiley has launched two new research journals, Advanced Medicine and Advanced Healthy Aging, as part of its expanding Advanced Portfolio. The new journals aim to elevate breakthrough science that impacts lives, reflecting Wiley's commitment to accelerating science that addresses humanity's most pressing challenges. Led by expert editori...

SourceWiley·DateSep 28, 2026

Human-Relevant Ptpn6 mutation reveals complex links between immunity, metabolism and liver aging

A new study published in Aging reveals that a mutation affecting the immune and metabolic regulator SHP-1 reshapes liver function during aging, showing improved glucose metabolism can coexist with immune-cell accumulation and liver fibrosis. The findings separate liver inflammation and fibrosis from insulin resistance, obesity and lipi...

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateSep 16, 2026

Rare Coombs-negative hemolytic anemia reported following pembrolizumab treatment

A new case report describes a 68-year-old woman with stage IV lung adenocarcinoma who developed severe hemolysis after receiving pembrolizumab, despite a negative Coombs test. The patient's hemoglobin declined from 11-12 g/dL to 6.4 g/dL, and laboratory markers of hemolysis improved with corticosteroid treatment. The case highlights th...

SourceImpact Journals LLC·JournalOncoscience·TypeCase study·DateSep 10, 2026

Restoring MHC-I expression could strengthen immune responses against CNS cancers

Researchers explored strategies to restore MHC-I expression in CNS cancers to make them more visible to the immune system. Approaches include epigenetic therapies, AAV vectors, PCSK9 inhibition, and modifying the tumor microenvironment. However, efficient delivery, antigen processing, and a limited neoantigen repertoire remain signific...

SourceImpact Journals LLC·JournalOncotarget·TypeLiterature review·DateSep 9, 2026

Three herbal extracts protect mitochondrial function in a cellular model of Parkinson’s disease

Researchers found three herbal extracts protect mitochondrial function in a cellular model of Parkinson’s disease, suggesting a potential treatment. The extracts, including Uncaria rhynchophylla, Gardenia jasminoides, and Scutellaria baicalensis, improved cell viability and mitochondrial function in cells with reduced VPS13C expression.

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateSep 9, 2026

Tumor-derived extracellular vesicles show promise for earlier detection of metastatic risk

Tumor-derived extracellular vesicles exhibit intrinsic organotropism and participate in establishing premetastatic niches, making them promising vehicles for targeted imaging probe delivery. However, current imaging approaches have limitations, including difficulty distinguishing between tumor-derived EVs and normal host cell-derived EVs.

SourceImpact Journals LLC·JournalOncotarget·TypeLiterature review·DateSep 1, 2026

Tumor-infiltrating lymphocyte therapy offers a promising approach for treating solid tumors

Tumor-infiltrating lymphocyte therapy has shown potential in several types of solid tumors, including metastatic melanoma, breast cancer, and ovarian cancer. Despite challenges, the approach has favorable clinical outcomes, and researchers are exploring combination strategies and advanced technologies to improve treatment durability.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateAug 31, 2026